Q&A

How are capital constraints impacting M&A and strategic partnerships in the CDMO and pharma sectors?

What economic or market trends are having the biggest impact on CDMO capacity and pipelines in 2025, and what will 2026 bring?

What do you see as the biggest threat to the CDMO industry in 2026 or beyond?

What do you consider to be the most important new tools or technology platforms currently being developed?

What Are the Keys to Making Rare Disease Drug Development Sustainable?

How Is The Pharmaceutical Industry Addressing Global Health Inequities?

What Are the Key Ethical and Regulatory Considerations as Gene Editing Technologies Advance Toward Widespread Clinical Use?

Q&A: Building A Burgeoning Advanced Therapy Infrastructure In The Middle East

Scroll to Top